Crewe Advisors LLC Iqvia Holdings Inc. Transaction History

Crewe Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$211.18 - $248.87 $4,012 - $4,728	19 Added 7.48%	273 $57,000
Q1 2024 May 13, 2024	BUY	$208.23 - $259.1 $52,890 - $65,811	254 New	254 $64,000
Q1 2023 May 12, 2023	SELL	$188.0 - $240.65 $4,324 - $5,534	-23 Reduced 44.23%	29 $5,000
Q4 2022 Feb 07, 2023	SELL	$172.45 - $226.53 $1,552 - $2,038	-9 Reduced 14.75%	52 $10,000
Q3 2022 Nov 14, 2022	BUY	$181.14 - $248.26 $1,630 - $2,234	9 Added 17.31%	61 $11,000
Q2 2022 Aug 02, 2022	BUY	$196.45 - $252.29 $10,215 - $13,119	52 New	52 $11,000
Q4 2020 Jan 27, 2021	SELL	$153.99 - $180.39 $4,619 - $5,411	-30 Closed	0 $0
Q3 2020 Oct 13, 2020	BUY	$141.28 - $169.75 $4,238 - $5,092	30 New	30 $5,000

1,106

141M

828K

951K

Ticker IQV
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 185,740,000
Market Cap $37.4B
Description
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Crewe Advisors LLC with notifications on news.